Table I.
Comparison between infectors and non-infectors
| Infectors (N = 21) a | Non-infectors (N = 35) a | P | |
|---|---|---|---|
| Age, years, median (IQR)b | 55 (41–62) | 47 (33–56) | 0.20 |
| Male sex | 11 (52) | 16 (46) | 0.63 |
| Patient | 8 (38) | 10 (29) | 0.56 |
| Caregiver | 10 (48) | 11 (31) | 0.23 |
| Underlying diseases | |||
| Immunocompromisedc | 3 (14) | 3 (9) | 0.66 |
| Healthcare worker | 3 (14) | 14 (40) | 0.04 |
| Symptomatic at diagnosis | 18 (86) | 24 (69) | 0.33 |
| Duration from symptom onset to confirmation, days, median (IQR) | 2 (0–5) | 0 (0–2) | 0.08 |
| Disease severity at time of diagnosis | |||
| Mild | 21 (100) | 34 (97) | > 0.99 |
| Moderate | 0 | 0 | NA |
| Severe | 0 (0) | 1 (3) | > 0.99 |
| Stay in a six-patient room d | 17/18 (94) | 19/21 (90) | > 0.99 |
Data are presented as N (%) of patients unless otherwise indicated. IQR, interquartile range.
a
Family cases (N = 9) were excluded because they did not acquire severe acute respiratory syndrome coronavirus 2 infection at the hospital.
b
Data from one individual were unavailable.
c
All six immunocompromised patients had haematologic malignancy.
d
Analysed for the patients and caregivers.